Abstract
Zhirong Liu1,*, Zhengzheng Wu1,*, Jie Li1, Anna Marmalidou2, Ruifan Zhang1 and Man Yu1
1Department of Ophthalmology, Hospital of University of Electronic Science and Technology of China and Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan 610072, China
2Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA 02114, USA
*These authors have contributed equally to this work
Correspondence to:
Man Yu, email: [email protected]
Keywords: resveratrol, aging, SAMP8 mice, light damage, retinal degeneration
Received: March 13, 2017 Accepted: June 24, 2017 Published: July 22, 2017
ABSTRACT
Purpose: The purpose of this study was to determine the protective effects of Resveratrol (RESV) on acute bright light-induced retinal degeneration in aged senescence accelerated mouse strain.
Methods: Ten three-month-old male SAMP8 mice (prone to aging) were randomly assigned to two experimental dietary groups: one untreated group and one RESV treatment group (n=20 eyes for each group). After 30 days of treatment, mice were exposed to intense bright light. Ten male SAMR1 mice (resistant to aging) served as control (n=20 eyes). The protective effects of RESV administration on light-induced retinal degeneration in SAMP8 strain as well as the effect of bright light damage in the retinas of SAMP8 mice were analyzed by electroretinography (ERG), retinal histology, mRNA, protein and lipid profile.
Results: 68%-85% of a-wave amplitude and 72%-92% of b-wave amplitude were persevered by RESV in SAMP8 mice that were exposed to light damage. Also, RESV preserved their photoreceptor nuclei. mRNA expression of neuroprotective factors leukemia inhibitory factor (LIF), brain derived neurotrophic factor (BDNF), oncostatin M (OSM), cardiotrophin 1(CT-1) and cardiotrophin-like cytokine (CLC) were up-regulated 28, 8, 7, 5 and 9-fold in SAMP8 mice after RESV treatment. In addition, RESV could suppress the NF-κB pathway by down-regulating the expression of pIκB. Light damage led to increase of saturated FA, monoenoic FA, n6 PUFA and n6/n3 ratio and decrease of Docosahexaenoic acid (DHA). There was no significant difference on DHA and the ratio of n6/n3-FA between the untreated and RESV treated SAMP8 mice.
Conclusions: Collectively, our study provides evidence that RESV prevents light-induced retinal damage associated with aging.
INTRODUCTION
Aging is associated with an increasing prevalence of neurodegenerative disorders and leads to irreversible alterations in humans and experimental animals [1]. The retina, a layer of nervous tissue that covers the inside of the back of the eyeball, is exposed to a variety of environmental insults and stressors, including age-associated alterations and lighting that impair its function. Light damage involves an oxidative stress that may contribute to the pathogenesis of several aging-related retinal degenerative diseases such as age-related macular degeneration (AMD) and diabetic retinopathy (DRP) [2, 3].
Resveratrol (3, 5, 4’-trihydroxy-trans-stilbene; RESV) [4], a phytoalexin naturally synthesized or induced in plants, is a widely known antioxidant and anti-inflammatory agent and has been shown to reverse age-associated pathologies in small mammals [5]. A recent study showed that administration of RESV decreases nuclear-factor kappa B (NF-κB) and reduces the proinflammatory and prooxidant status associated with aging, which restores the function of the affected pancreas of aged SAMP8 mice [6]. The senescence-accelerated prone mouse (SAM) was established from the AKR/J strain. The SAM mice include 9 strains of accelerated-senescence prone, short-lived mice (SAMP) and 3 strains of accelerated senescence-resistant, long-lived mice (SAMR), which has been extensively studied to understand age-related human diseases [7, 8]. Among SAMP mice, SAMP8 mice have been extensively used in previous studies to investigate the effect of aging in different organs as mentioned above in pancreas. Also, these aging mice are considered as a good model of Alzheimer’s disease to study the fundamental mechanisms of age-associated deficiencies in learning and memory [9]. Interestingly, a number of striking similarities between Alzheimer’s disease and AMD have been described. Both represent a complex and multi-factorial degeneration of central nervous system in which aging is a primary risk factor [10]. In addition to age-associated changes in the brain, the SAMP mice also demonstrate neuronal cell degeneration in the retina [11]. Aged SAMP8 mice have been recently shown to develop retinopathy similar to some features of human AMD including Aβ deposition and increased inflammatory response in the outer retina [12].
Age-related susceptibility of retinal photoreceptors to light-induced degeneration was strongly influenced by exposure to different intensities of environment light. Daniel and coworkers have reported significant differences in the extent of light damage in two- to twelve-month-old albino rats [13]. The aim of our study was to determine the protective effects of RESV on acute bright light-induced retinal degeneration in an aging animal model using SAMP8 mice for the first time in the study of light-induced retinal degeneration.
RESULTS
Functional evaluation with electroretinography (ERG)
To understand the role of RESV in the aging retina, RESV was administered to SAMP8 mice, which were then subjected to severe light stress at 2,700 lux for 4h and returned to standard light conditions. After 7 days of recovery, ERG was performed on all mice to evaluate their retinal function. The ERG a-wave and b-wave are the major components of murine ERG recording and are comprehensively studied. It is generally accepted that the a-wave of scotopic ERG is mainly derived from rod photoreceptors in response to a flashed stimulus and cone-driven a-wave is relatively negligible under light-adapted (photopic) conditions [14]. The ERG b-wave represents the activity of cone photoreceptors and originates from the inner retinal neurons [15]. Therefore, in this study, we analyzed the changes on amplitudes of scotopic a-wave and scotopic and photopic b-wave that reflect rod and cone function respectively. As expected, the untreated SAMP8 mice that were exposed to light damage showed significantly reduced amplitude of scotopic a-wave (Figure 1A), scotopic b-wave (Figure 1B), and photopic b-wave (Figure 1C). Furthermore, the exacerbation of cone function in SAMP8 without RESV treatment was reflected by the significant reduction in the flicker ERG that originates primarily in the inner retina (Figure 1D). However, SAMP8 mice that were administered with RESV were capable to maintain their retinal function. Consequently, approximately 68%-85% of rod-driven a-wave amplitude and 72%-92% of cone-driven b-wave amplitude were persevered by RESV.
Figure 1: RESV prevented the rod and cone degeneration of aged SAMP8 mice from light damage. (A) and (B): scotopic d a-wave and b-wave amplitudes of SAMR1 and SAMP8 mice that have been light damaged (2,700 lux for 4h) with or without RESV supplementation; The stimulus intensities for scotopic ERG were −5 followed by −3, -1, 1and 1.2 log cd.s/m2. (C) photopic b-wave amplitude: photopic 600 lux, short-wave-sensitive cone (S-cone)-mediated and middle-wave-sensitive cone (M-cone)-mediated ERG response were recorded. (D) The flicker response was taken with 3Hz, 10Hz and 15Hz light flicks. n=20; value=Mean±SE (*p<0.05, vs. SAMP8+LD, paired t-test).
Morphologic evaluation with quantitative histology
After ERG analysis, we evaluated the extent of photoreceptor cell loss by quantitative histology. The number of layers of photoreceptor nuclei in the outer nuclear layer (ONL) was analyzed as described by Ueki et al [16]. Figure 2A and 2B showed representative sections of the inferior retina and quantitative alterations in photoreceptor nuclei in ONL, respectively. Compared with SAMR1 undamaged retinas that contain 10-11 layers of photoreceptor nuclei in the ONL, SAMP8 mice following light exposure without treatment retained only 2-4 layers of photoreceptor nuclei. However, while SAMP8 mice with RESV supplementation suffered from severe light stress, their retinal degeneration was mild as they retained 8–9 layers of photoreceptor nuclei. These data demonstrate that exposure to 2700lux light for 4h resulted in significant loss of photoreceptor nuclei in the ONL of the retina in the untreated group. A great preservation of photoreceptor nuclei in the RESV-treated group was observed (P<0.01, vs. SAMP8+LD).
Figure 2: RESV preserved the structure of photoreceptor layer of aged SAPM8 mice that were exposed to light damage. (A) Representative sections and (B) quantification of number of layers of photoreceptor nuclei in the outer nuclear layer (ONL) along the vertical meridian of the retina. n=10; value=Mean±SE (*p<0.01, vs. SAMP8+LD, paired t-test). ONL-Outer nuclear layer; INL-Inner nuclear layer; GCL-Ganglion cell layer; ON-Optic nerve.
Expression of neuroprotective factors after RESV treatment
One of the protective mechanisms of the retina to resist light damage is to regulate the levels of neuroprotective cytokines [17]. IL-6 family cytokines including leukemia inhibitory factor (LIF) [16], basic ciliary neurotrophic factor (CNTF) [18], oncostatin M (OSM) [19], cardiotrophin-1(CT-1) [20], and cardiotrophin-like cytokine (CLC) [21] have been reported to protect photoreceptors in different animal models. In addition, an increase in gene expression of brain derived neurotrophic factor (BDNF) was observed under light-induced damage in a previous study [22]. To determine which factors could contribute to the protective effect of RESV in SAMP8 mice that were exposed to light stress, levels of gene expression of those neuroprotective factors were quantified using real-time PCR. Ribosomal protein RPL19 was used as housekeeping gene. Comparison of expression of different genes relative to the expression of RPL19 (Figure 3A) showed that LIF, OSM, CT-1 and CLC were up-regulated 28, 7, 5 and 9-fold in SAMP8 mice after RESV treatment. BDNF expression exhibited an 8-fold increase. However, we did not observe any up-regulation of CNTF in SAMP8 mice.
Figure 3: RESV supplementation leads to up-regulation of neuroprotective factors. (A) Quantitative evaluation of cytokine mRNA expression levels using real-time PCR. Comparison of quantitative expression of different genes presented relative to the expression of the housekeeping gene RPL19. The values represent the Mean±SD (n=4) after normalizing with RPL19 calculated by the comparative threshold cycle method. LIF, BDNF, OSM, CT-1 and CLC exhibit a significant up-regulation of 28, 8, 7, 5 and 9-fold respectively in SAMP8 mice with RESV treatment (*p<0.05, **P<0.01, ***P<0.001, vs. SAMP8+LD, unpaired t-test). (B) Representative western blots and (C) Quantification of protein expression levels of pIκBα, n=3, value=Mean±SD. An increase in pIκB protein was observed in SAMP8 mice with RESV treatment. (*p<0.05, vs. SAMP8+LD, unpaired t-test).
Furthermore, it has been postulated that RESV not only curbs expression of NF-κB, but also impedes the phosphorylation of IκB (pIκB) thereby keeping the constitutive NF-κB subunit in an inactive state, resulting in suppression of the inflammatory alteration [23]. Protein levels of pIκB were measured to evaluate the inactivation of NF-κB. Figure 3B and 3C demonstrate that RESV supplementation could suppress the NF-κB pathway by down-regulating the expression of pIκB.
Fatty acid (FA) analysis
A recent study showed that RESV exhibits the effects on the metabolic kinetics of sphingosine 1-phosphate, a multi-functional phospholipid, and that high concentration of RESV could increase LDL receptor expression [24]. We speculated that RESV might affect the metabolism of saturated and/or unsaturated FAs in the retina. Fatty acid composition in the retinas were analyzed by GC-MS. Compared to the untreated SAMP8 mice, the retinas of RESV treated mice had lower relative mole% of the 16:0 (Saturated FA), 18:1 (Monoenoic FA), 18:2n6 and 20:4n6 (n6 Polyunsaturated FA, PUFA). There was no significant difference in 20:5n3 (Eicosapentaenoic acid, EPA), 22:6n3 (Docosahexaenoic acid, DHA) and the ratio of n6/n3-FA between the untreated and RESV treated SAMP8 mice. Compared to the undamaged retinas of SAMR1 control mice, the retinas of RESV treated SAMP8 mice had higher 16:0 and 18:1, and lower DHA. Light damage to the retinas of SAPM8 mice not only led to an increase of 16:0, 18:1 and 18:2n6, but also decrease of DHA. Although the average of n6/n3-FA ratio in SAMP8+LD group was almost twice more than that of SAMP8+LD+RESV group, there was no significant difference in the n6/n3-FA ratio between those two groups. However, a significant increase of n6/n3-FA ratio was observed in the retinas of SAMP8+LD group without treatment when compared to that of SAMR1 control mice (Table 1).
Table 1: Relative mole percentage (±SD) of fatty acid composition from mice retina
FA | SAMP1 (a) | SAMP8+LD +RESV (b) | SAMP8+LD (c) | P value (a) vs.(b) | P value (b) vs.(c) | P value (a) vs.(c) |
|---|---|---|---|---|---|---|
14:0 | 0.44±0.08 | 0.53±0.16 | 0.3±0.03 | > 0.05 | > 0.05 | > 0.05 |
16:0 | 15.1±0.48 | 18.33±1.44 | 19.67±0.28 | < 0.001 | < 0.01 | < 0.001 |
16:1 | 1.93±0.15 | 2.45±0.4 | 1.95±0.64 | > 0.05 | > 0.05 | > 0.05 |
18:0 | 16.22±0.29 | 16.03±0.27 | 16.68±0.37 | > 0.05 | > 0.05 | > 0.05 |
18:1 | 15.41±0.64 | 18.71±0.17 | 27.27±0.8 | < 0.001 | < 0.001 | < 0.001 |
18:2n6 | 7.49±0.16 | 7.72±0.07 | 9.51±0.43 | > 0.05 | < 0.001 | < 0.001 |
18:3n6 | 0.04±0.00 | 0.06±0.01 | 0.08±0.01 | > 0.05 | > 0.05 | > 0.05 |
18:3n3 | 0.55±0.17 | 0.65±0.09 | 0.26±0.02 | > 0.05 | > 0.05 | > 0.05 |
20:0 | 0.83±0.02 | 0.81±0.05 | 1.09±0.05 | > 0.05 | > 0.05 | > 0.05 |
20:1 | 0.9±0.03 | 0.87±0.05 | 1.56±0.12 | > 0.05 | > 0.05 | > 0.05 |
20:5n3 | 0.26±0.02 | 0.36±0.09 | 0.15±0.09 | > 0.05 | > 0.05 | > 0.05 |
20:2n6 | 0.41±0.02 | 0.32±0.02 | 0.55±0.02 | > 0.05 | > 0.05 | > 0.05 |
20:3n6 | 0.39±0.03 | 0.22±0.03 | 0.27±0.08 | > 0.05 | > 0.05 | > 0.05 |
20:4n6 | 3.46±0.06 | 3.44±0.05 | 4.93±0.07 | > 0.05 | < 0.001 | < 0.001 |
22:0 | 0.65±0.01 | 0.60±0.03 | 0.81±0.03 | > 0.05 | > 0.05 | > 0.05 |
22:1 | 0.27±0.01 | 0.26±0.02 | 0.36±0.02 | > 0.05 | > 0.05 | > 0.05 |
22:4n6 | 0.29±0.01 | 0.33±0.01 | 0.32±0.02 | > 0.05 | > 0.05 | > 0.05 |
22:5n6 | 0.49±0.01 | 0.13±0.01 | 0.23±0.01 | > 0.05 | > 0.05 | > 0.05 |
22:5n3 | 1.33±0.09 | 1.28±0.58 | 1.09±0.13 | > 0.05 | > 0.05 | > 0.05 |
22:6n3 | 15.05±2.09 | 13.35±3.87 | 12.5±1.16 | < 0.001 | > 0.05 | < 0.001 |
24:0 | 0.86±0.04 | 0.88±0.03 | 0.84±0.06 | > 0.05 | > 0.05 | > 0.05 |
24:1 | 0.66±0.00 | 0.57±0.02 | 0.68±0.04 | > 0.05 | > 0.05 | > 0.05 |
24:6n3 | 0.07±0.01 | 0.02±0.00 | 0.02±0.01 | > 0.05 | > 0.05 | > 0.05 |
32:6n3 | 0.16±0.03 | 0.10±0.05 | 0.04±0.01 | > 0.05 | > 0.05 | > 0.05 |
34:5n3 | 0.11±0.02 | 0.09±0.05 | 0.04±0.01 | > 0.05 | > 0.05 | > 0.05 |
34:6n3 | 0.20±0.03 | 0.15±0.08 | 0.05±0.01 | > 0.05 | > 0.05 | > 0.05 |
n6/ n3 ratio | 0.40±0.02 | 0.68±0.03 | 1.12±0.53 | > 0.05 | > 0.05 | < 0.05 |
FA: fatty acid
Relative mol%s (±SD, n=3) of FA from total lipids extracted from sample homogenate equivalent to 2.0 mg of protein were converted to FAME and analyzed by GC-FID. Multivariate ANOVA followed by posthoc Scheffe test was used to compare the data from the different groups.
DISSCUSION
RESV has garnered much attention as a phytochemical, which exerts antioxidant and anti-inflammatory effects in various mammalian aging models [5, 25]. Those studies provided increasing evidence that RESV has beneficial effects in neurodegenerative diseases such as AD [26], Parkinson’s Disease (PD) [27], and Amyotropic Lateral Sclerosis (ALS) [28, 29]. Recently, protective effects of RESV have been investigated in vitro on retinal pigment epithelium cell death resulting from blue-light-induced damage [30], and in vivo on the rat model of diabetic retinopathy [31]. In this study, the effect of RESV in light-induced retinal damage of SAMP8 mice was analyzed to understand the mechanism of restoration of function of the affected retina following RESV administration in an aging animal model.
Initially, we used the intensity of 4000 lux for 6 hours that caused severe irreversible damage in the retina of SAMP8 mice and RESV couldn’t prevent this damage (data not shown). Then, we reduced the light intensity to 2,700 lux for 4 hours, which induced the morphological changes in the SMAP8 mice as we showed in Figure 2A. As described above, aging is a well-known risk factor for retinal degenerative diseases and light damage involves an oxidative process that may trigger apoptosis in the light-sensitive retina. A previous study showed that the retina in older rats sustained more damage from exposure to intense light compared to retina derived from younger ones [13]. Actually, in our study, this moderate intensity of 2,700 lux for 4 hours didn’t cause the morphological damage in the SAMR1 control mice, but the slight alterations of ERG function (data not shown), suggesting that SAMP8 mice are more susceptible to light exposure than SAMR1 mice.
Out data showed that RESV could preserve retinal structure and function of SAMP8 mice that were exposed to severe light stress. However, the underlying protective mechanisms remain unclear. It has been reported that RESV could induce neuronal differentiation of medulloblastoma cells via increased production and secretion of LIF [32]. Previous studies have demonstrated that intraocular injection of LIF and CNTF can protect photoreceptor from light damage [16, 21, 33]. In our experiments with RESV supplementation, we observed a significant up-regulation of neuroprotective factors LIF, OSM and CLC (Figure 3A). However, CNTF was not up-regulated in the retinas of SAMP8 mice in response to RESV treatment. The increase in CNTF in response to preconditioning was observed in rats, but not in mice [34, 35], which implied that the differences in neuroprotective actions of endogenous factors might be associated with species differences. Actually, we also observed that cytokine CT-1 was up-regulated 5-fold in SAMP8 mice after RESV treatment, but there was no significant difference between the untreated and treated group. In addition, up-regulation of the neuroprotective factor BDNF was observed in the retinas of the treatment group. BDNF plays an essential role in the maintenance and survival of neurons and oligodendrocytes. It was postulated that RESV can promote the release of neurotrophic factors including BDNF in the central nervous system [36]. Our findings also support that RESV could mediate the up-regulation of BDNF in the light-damaged retina.
The causes of aging are due to multi-factorial processes. It is well known that aging is associated with inflammation, NF-κB activation, increased apoptosis, impaired mitochondrial activity, and a decline in immune function, as well as increased free-radical production rate [6]. Our results showed a decrease in pIκB expression levels in SAMP8 mice with RESV treatment (Figure 3B and 3C), which is consistent with observations from previous studies [1, 6, 37]. Therefore, it is plausible that RESV can mediate anti-inflammatory and/or anti-oxidation effects via inhibiting NF-κB pathway.
In animal models, n3 PUFA supplementation has been shown to enhance [38] or prevent [39, 40] the reduction in ERG a- and b-wave amplitudes after transient ischemia. In the 1970s, Anderson and colleagues demonstrated that FA composition in rod outer segment membranes of rodent retina is an essential determinant for optimal retinal function. In addition, they showed that reduction of PUFA in mouse retinas leads to changes in retinal function measured by reduced amplitudes of their ERG [41, 42]. Extensive studies reported that alterations in n3 fatty acids, especially DHA and EPA are associated with alteration of photo-transduction efficiency, which in turn affect ERG responses [43, 44]. Therefore, we speculated that altered FA composition in the retinas of the RESV-treated mice likely helped maintain the ERG a- and b- wave amplitude. In our experiments, we found that light damage led to the increase of saturated FA, monoenoic FA, n6 PUFA and n6/n3 ratio (Table 1, SAMP1 vs SAMP8+LD). Even though the retinas of SAMP8 mice with RESV treatment still had lower DHA, RESV suppressed the levels of n6 PUFA as there is no difference in n6/n3 ratio between the two groups of SAMP1 and SAMP8+LD+RESV (Table 1). Studies on the protective effect of DHA for retinal function are controversial. Li and Anderson et al showed that DHA is not beneficial for the treatment of retinal degeneration in the animal model of Stargardts-like macular dystrophy [45]. Very long chain PUFAs are FAs of the n3 and n6 series with greater than C26 carbons. These unique groups of FAs are found mostly in the retina, brain, testis, and spermatozoa [46]. Ongoing studies have reported reduced levels of very long chain polyunsaturated FAs in aging retinas and in retinas of donor eyes of patients with a history of AMD [47]. We also noticed that light damage resulted in decrease in very long chain n3 PUFA (32:6n3, 34:5n3 and 34:6n3) and that RESV may maintain the levels of very long chain PUFA. However, there was no significant difference in their alteration due to the limited number of samples.
In conclusion, RESV administration is able to protect both the retinal structure and function of SAMP8 mice from severe light exposure via increasing expression of neuroprotective factors, as well as decreasing expression of pIκB. In the light of these results, RESV may be a beneficial agent that can exert a protective effect against light-induced retinal damage associated with aging. This study suggests that RESV may maintain the morphology and function of retina suffering from oxidative and/or inflammatory stress in aging retinal diseases including AMD and DRP.
MATERIALS AND METHODS
Animals and treatment
One-month-old male SAMP8 and SAMR1 mice were purchased from Nanjing qingzilan Co. Ltd. (Nanjing, China). All animals were used according to the guidelines of ethical committee of experimental animal care at Sichuan Provincial People’s Hospital of China. Mice were housed in an air-conditioned room with a 12h light/dark cycle, a constant temperature of 22 ± 2 °C, and relative humidity of 65 ± 15%. At 3 months old, the SAMP8 mice were randomly assigned to two experimental dietary groups: one untreated group and one RESV treatment group, each group contained 10 animals (20 eyes). Male SAMR1 mice (n=20 eyes), which showed normal characteristics, were used as the external control. Resveratrol was purchased from Actafarma (Madrid, Spain) and administered to the animals at a dose of 5 mg/kg/day. As mentioned in a previous study, water consumption of individual animals was estimated to be 0.8mL/10g body weight/day, which implied a water intake of about 2.5mL/day for each mouse of 3 months of age weighing around 30g [6]. Therefore, a solution of 6mg/100mL was prepared, which consisted of 0.15mg in the estimated 2.5mL of water/day. Resveratrol was dissolved in absolute ethanol and added to the drinking water to a final ethanol concentration of 0.066%. Water bottles were covered with aluminium foil to be protected from light, and the drinking fluid was changed every day. Non-treated animals received 0.1% alcohol in tap water.
After 30 days of feeding, both untreated and RESV treatment groups were exposed to intense bright light at 2,700 lux for 4h (acute light stress). After intense light exposure, these two groups were returned to their native dim cyclic light and fed their respective diets. Retinal function was measured with electroretinography (ERG) after one week of light damage. Then all the mice were euthanized with CO2 from a compressed gas tank in an euthanization chamber followed by cervical dislocation, and their eyeballs were harvested for retinal histological analysis.
Electroretinography (ERG)
Flash ERGs were recorded with an ERG recording system (Diagnosys, Littleton, MA); for additional details refer to previous publications [48] [14]. Mice were maintained in total darkness overnight and were prepared for ERG recording in dim red light. Each mouse was anesthetized with ketamine (120mg/kg bodyweight intramuscularly) and xylazine (6mg/kg bodyweight, intramuscularly). One drop of 10% phenylephrine was applied to the cornea to dilate the pupil, and one drop of 0.5% proparacaine HCl was applied for local anesthesia. A reference electrode was positioned in the mouth and a ground electrode on the foot, and the mouse was placed inside a Ganzfeld illuminating sphere with a gold electrode placed on the cornea. Five increasing strobe flashes were used starting at an intensity of −5 followed by −3, -1, 1and 1.2 log cd.s/m2, and the ERG responses from both eyes were recorded to assess rod photoreceptor function (scotopic ERG). To evaluate cone function (photopic ERG), the mice were light adapted to 2 minutes exposure to a 32 cd/m2 background in the Ganzfeld to saturate the rod response. ERG recording was conducted with a brief white flash intensity ranging from -0.53 to +2.0 log cd.s/m2 flash. The flicker response was taken with 3Hz, 10Hz and 15Hz light flicks. The responses were computer averaged and recorded at 3–60 s intervals depending on flash intensity. For recording Short-wave-sensitive cone (S-cone)-mediated and middle-wave-sensitive cone (M-cone)-mediated ERG response, the mice were first light-adapted for 2 min in green light with 20cd/m2 intensity. ERG was recorded by alternating green and UV flashes. The intensities ranged from 0.1671×104 to 55.7×104 photon/μm2 for green flashes and from 0.0113×104 to 33.9×104 photon/μm2 for UV flashes, with a background green illumination of 20 cd/m2. The amplitude of the a-wave was measured from the pre-stimulus baseline to the a-wave trough. The amplitude of the b-wave was measured from the trough of the a-wave to the peak of the b-wave.
Histological analysis
Mice were euthanized with CO2 and the eyes were enucleated and marked with a green dye on dorsal surface to mark the superior hemisphere. Eyes were then fixed in PERFIX (20% isopropanol, 2% trichloroacetic acid, 4% paraformaldehyde, and 2% zinc chloride) overnight and placed in 70% ethanol at room temperature for 4 days followed by embedding in paraffin. Sagittal sections through the center of the eye, including the optic disc, were cut at 5 μm thickness. After hematoxylin and eosin (H&E) staining, rows of photoreceptor nuclei were counted using light microscopy at nine equidistant points beginning at the optic nerve head toward both the inferior and superior retinal hemispheres.
Real-time PCR
mRNA levels of selected genes were measured using real-time PCR with cDNA extracted from retinas as templates. Primers (Table 2) were designed using Primer Quest software (Integrated DNA Technologies, Coralville, IA, USA) spanning the intron–exon boundary to amplify the corresponding mRNAs without amplifying potentially contaminating genomic DNA. Real-time PCR was carried out with the SYBR green PCR master mix (Bio-Rad Lab., Hercules, CA, USA) using the MyiQ Single-Color Real-Time PCR detection system (Bio-Rad Lab., Hercules, CA, USA) according to the manufacturer’s instructions. Electrophoresis of PCR products was performed to identify that a single band of the correct size had been amplified.
Table 2: Sequence of the primers used for RT-PCR
Gene | Sequence |
|---|---|
LIF | F:5’-TGAGATGCAGGGATTGTGCCCTTA-3’ |
R:5’-AAATGAAGAGAGCATTGGCGCTGC-3’ | |
CNTF | F:5’-AGAGCAATCACCTCTGACCCTTCA-3’ |
R:5’-ATCTCACTCCAGCGATCAGTGCTT-3’ | |
BDNF | F:5’-AGAAGGTTCGGCCCAACGAAGAAA-3’ |
R:5’-GACATGTTTGCGGCATCCAGGTAA-3’ | |
OSM | F:5’-TTTGACCCTCAGTCTCCTCATCCT-3’ |
R:5’-AGGGCTCCAAGAGTGATTCTGTGT-3’ | |
CT-1 | F:5’-AAGACCACCAGACTGACTCCTCAA-3’ |
R:5’-GCTGCACGTATTCCTCCAGAAGTT-3’ | |
CLC | F:5’- ACGAGCCTGACTTCAATCCTCCT-3’ |
R:5’- ACGCAAGTAACACAGGAGGTGACT-3’ | |
RPL19 | F:5’-TCACAGCCT-GTACCTGAAGG-3’ |
R:5’-TCGTGCTTCCTTGGTCTTAG-3’ |
Western blots
Retinas were harvested immediately after animals were euthanized and homogenized in a lysis buffer (50mM Tris–HCl (pH=7.5), 150mM NaCl, 5mM EDTA, 1% (v/v) NP-40, 5% (v/v) glycerol, and protease inhibitor cocktail (Calbiochem, San Diego, CA). Protein content was measured using BCA protein assay (Pierce, Rutherford, IL). Total protein from each sample (15μg) was electrophoresed on 4–20% gradient SDS polyacrylamide gels (Invitrogen, Carlsbad, CA), and transferred to nitrocellulose membranes (Bio-Rad, Hercules, CA). The membranes were incubated in blocking buffer [5% BSA in TBST (20mMTris–HCl, pH 7.5, 100mMNaCl, and 0.1% Tween-20)] for 1 h at room temperature, and then incubated overnight at 4°C with rabbit polyclonal anti-phospho-IκBα antibody (#2859, Cell Signaling Technology, Beverly, MA), in blocking buffer, followed by 1-hour incubation at room temperature with HRP-conjugated goat anti-rabbit secondary antibody (Amersham Biosciences, Piscataway, NJ). Signals were visualized using Super Signal West Dura extended duration substrate (Pierce, Rutherford, IL) and quantified by conventional digital image analysis using an Image Station 4000R (Eastman Kodak, Rochester, NY). Blots were stripped and reprobed with rabbit polyclonal anti-β actin (ab6276, Abcam) followed by appropriate secondary antibodies for quantification of bands.
Retinal fatty acid analysis
Retinas were harvested from all the experimental mice and frozen immediately in liquid nitrogen. Retinal lipids were subsequently extracted following the method of Bligh Dyer technique [49] with minor modification [50]. The purified lipid extract was stored under nitrogen until used. To the purified lipid extracts, 50nmol of 15:0, 17:0, 23:0 each were added as internal standards. One milliliter of 16.6% concentrated HCl in methanol was then added and the tubes were sealed under N2 with Teflon-lined caps and heated at 100°C overnight. The tubes were cooled on ice and FA methyl esters (FAMEs) were extracted and processed as previously reported [51].
FAMEs were identified using an Agilent Technologies 7890A gas chromatograph (GC) with a 5975C inert XL mass spectrometer (MS) detector (Agilent Technologies; Santa Clara, CA). The GC-MS was operated in the electron impact total-ion and single-ion monitoring (SIM) modes. The injection volume was 1μl and the inlet, held at 280°C, was set to pulsed splitless mode. An Agilent Technologies DB-23 column (60m × 0.32mm × 0.25μm) was used with a helium carrier gas flow rate of 1.9 ml/min. The oven temperature began at 130°C for 1.0 min, was ramped to 170°C at 6.8°C/min, and then ramped to 215°C at 2.9°C/min. After holding at 215°C for 11.4 min, the oven was ramped to 230°C at 42°C/min and held for 9.6 min. The oven was then ramped to 290°C at 10°C/min and held for 14.4 min. The MS transfer line, ion source, and quadrupole temperatures were 290°C, 230°C, and 150°C, respectively. The PUFAs were identified by using the m/z ratios 79.1, 108.1, and 150.1 in SIM mode and the full scan mass spectra in total-ion mode. FAMEs were quantified using an Agilent Technologies 6890N GC with flame ionization detector (FID). Sample concentrations were determined by comparison to internal standards 15:0, 17:0, 23:0, and 30:3n6. The injection volume was 1 μl and the inlet, held at 280°C, was set to pulsed split mode (10:1 ratio). An Agilent Technologies DB-23 column (60m×0.32mm×0.25μm) was used with a hydrogen carrier gas constant pressure of 13.1 psi. The oven temperature began at 130°C for 0.8 min, was ramped to 170°C at 8.2°C/min then ramped to 215°C at 3.5°C/min. After holding at 215°C for 9.5 min, the oven was ramped to 230°C at 50°C/min and held for 8 min. The oven was then ramped to 290°C at 12.0°C/min and held for 12 min. The FID was held at 290°C.
Statistical analysis
The statistical analysis was performed using GraphPad Prism 6 (GraphPad Software, La Jolla, CA). Results of ERG and HE are expressed as Mean±Standard Error (SE). Since there are only 3 or 4 samples in RT-PCR, western blots and fatty acid analysis, those results are expressed as Mean±Standard Deviation (SD). Differences between two groups were assessed using either paired or unpaired t-tests, while differences between more than two groups were assessed using Multivariate ANOVA followed by posthoc Scheffe test. A p value less than 0.05 was considered significant.
Author contributions
Man Yu, Zhirong Liu and Zhengzheng Wu designed the study and contributed to the manuscript writing. Zhirong Liu and Man Yu performed the experiments. Jie Li analyzed the data. Ruifan Zhang collected the data. Anna Marmalidou helped to revise the manuscript.
ACKNOWLEDGMENTS
This study was mostly supported by the grants from PhD Support Program of Sichuan Provincial People’s Hospital (No. 30305030830
CONFLICTS OF INTEREST
The study is not industry sponsored. The authors have no disclosures with regard to this report. There are no conflicts of interest.
REFERENCE
1. Hao ZH, Huang Y, Wang MR, Huo TT, Jia Q, Feng RF, Fan P, Wang JH. SS31 ameliorates age-related activation of NF-kappaB signaling in senile mice model, SAMP8. Oncotarget. 2017; 8:1983-1992. doi: 10.18632/oncotarget.14077.
2. Calzia D, Garbarino G, Caicci F, Manni L, Candiani S, Ravera S, Morelli A, Traverso CE, Panfoli I. Functional expression of electron transport chain complexes in mouse rod outer segments. Biochimie. 2014; 102:78-82.
3. Rezaie T, McKercher SR, Kosaka K, Seki M, Wheeler L, Viswanath V, Chun T, Joshi R, Valencia M, Sasaki S, Tozawa T, Satoh T, Lipton SA. Protective effect of carnosic acid, a pro-electrophilic compound, in models of oxidative stress and light-induced retinal degeneration. Invest Ophthalmol Vis Sci. 2012; 53:7847-7854.
4. Iwuchukwu OF, Nagar S. Resveratrol (trans-resveratrol, 3,5,4’-trihydroxy-trans-stilbene) glucuronidation exhibits atypical enzyme kinetics in various protein sources. Drug Metab Dispos. 2008; 36:322-330.
5. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006; 444:337-342.
6. Gines C, Cuesta S, Kireev R, Garcia C, Rancan L, Paredes SD, Vara E, Tresguerres JA. Protective effect of resveratrol against inflammation, oxidative stress and apoptosis in pancreas of aged SAMP8 mice. Exp Gerontol. 2017; 90:61-70.
7. Okuma Y, Nomura Y. Senescence-accelerated mouse (SAM) as an animal model of senile dementia: pharmacological, neurochemical and molecular biological approach. Jpn J Pharmacol. 1998; 78:399-404.
8. Takeda T. Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice. Neurochem Res. 2009; 34:639-659.
9. Wu FJ, Xue Y, Liu XF, Xue CH, Wang JF, Du L, Takahashi K, Wang YM. The protective effect of eicosapentaenoic acid-enriched phospholipids from sea cucumber Cucumaria frondosa on oxidative stress in PC12 cells and SAMP8 mice. Neurochem Int. 2014; 64:9-17.
10. Sivak JM. The aging eye: common degenerative mechanisms between the Alzheimer’s brain and retinal disease. Invest Ophthalmol Vis Sci. 2013; 54:871-880.
11. Hosokawa M, Ueno M. Aging of blood-brain barrier and neuronal cells of eye and ear in SAM mice. Neurobiol Aging. 1999; 20:117-123.
12. Feng L, Cao L, Zhang Y, Wang F. Detecting Abeta deposition and RPE cell senescence in the retinas of SAMP8 mice. Discov Med. 2016; 21:149-158.
13. Organisciak DT, Darrow RM, Barsalou L, Darrow RA, Kutty RK, Kutty G, Wiggert B. Light history and age-related changes in retinal light damage. Invest Ophthalmol Vis Sci. 1998; 39:1107-1116.
14. Mookherjee S, Hiriyanna S, Kaneshiro K, Li L, Li Y, Li W, Qian H, Li T, Khanna H, Colosi P, Swaroop A, Wu Z. Long-term rescue of cone photoreceptor degeneration in retinitis pigmentosa 2 (RP2)-knockout mice by gene replacement therapy. Hum Mol Genet. 2015; 24:6446-6458.
15. Stockton RA, Slaughter MM. B-wave of the electroretinogram. A reflection of ON bipolar cell activity. J Gen Physiol. 1989; 93:101-122.
16. Ueki Y, Wang J, Chollangi S, Ash JD. STAT3 activation in photoreceptors by leukemia inhibitory factor is associated with protection from light damage. J Neurochem. 2008; 105:784-796.
17. Wilson RB, Kunchithapautham K, Rohrer B. Paradoxical role of BDNF: BDNF+/- retinas are protected against light damage-mediated stress. Invest Ophthalmol Vis Sci. 2007; 48:2877-2886.
18. LaVail MM, Unoki K, Yasumura D, Matthes MT, Yancopoulos GD, Steinberg RH. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc Natl Acad Sci U S A. 1992; 89:11249-11253.
19. Xia X, Li Y, Huang D, Wang Z, Luo L, Song Y, Zhao L, Wen R. Oncostatin M protects rod and cone photoreceptors and promotes regeneration of cone outer segment in a rat model of retinal degeneration. PLoS One. 2011; 6:e18282.
20. Song Y, Zhao L, Tao W, Laties AM, Luo Z, Wen R. Photoreceptor protection by cardiotrophin-1 in transgenic rats with the rhodopsin mutation s334ter. Invest Ophthalmol Vis Sci. 2003; 44:4069-4075.
21. Chollangi S, Wang J, Martin A, Quinn J, Ash JD. Preconditioning-induced protection from oxidative injury is mediated by leukemia inhibitory factor receptor (LIFR) and its ligands in the retina. Neurobiol Dis. 2009; 34:535-544.
22. Ortin-Martinez A, Valiente-Soriano FJ, Garcia-Ayuso D, Alarcon-Martinez L, Jimenez-Lopez M, Bernal-Garro JM, Nieto-Lopez L, Nadal-Nicolas FM, Villegas-Perez MP, Wheeler LA, Vidal-Sanz M. A novel in vivo model of focal light emitting diode-induced cone-photoreceptor phototoxicity: neuroprotection afforded by brimonidine, BDNF, PEDF or bFGF. PLoS One. 2014; 9:e113798.
23. Whitlock NC, Baek SJ. The anticancer effects of resveratrol: modulation of transcription factors. Nutr Cancer. 2012; 64:493-502.
24. Kurano M, Hara M, Nojiri T, Ikeda H, Tsukamoto K, Yatomi Y. Resveratrol exerts a biphasic effect on apolipoprotein M. Br J Pharmacol. 2016; 173:222-233.
25. Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E, Jamieson HA, Zhang Y, Dunn SR. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 2008; 8:157-168.
26. Marambaud P, Zhao H, Davies P. Resveratrol promotes clearance of Alzheimer’s disease amyloid-beta peptides. J Biol Chem. 2005; 280:37377-37382.
27. Lofrumento DD, Nicolardi G, Cianciulli A, De Nuccio F, La Pesa V, Carofiglio V, Dragone T, Calvello R, Panaro MA. Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson’s-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses. Innate Immun. 2014; 20:249-260.
28. Song L, Chen L, Zhang X, Li J, Le W. Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Biomed Res Int. 2014; 2014:483501.
29. Mancuso R, del Valle J, Modol L, Martinez A, Granado-Serrano AB, Ramirez-Nunez O, Pallas M, Portero-Otin M, Osta R, Navarro X. Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice. Neurotherapeutics. 2014; 11:419-432.
30. Kang JH, Choung SY. Protective effects of resveratrol and its analogs on age-related macular degeneration in vitro. Arch Pharm Res. 2016; 39:1703-1715.
31. Zeng K, Yang N, Wang D, Li S, Ming J, Wang J, Yu X, Song Y, Zhou X, Yang Y. Resveratrol prevents retinal dysfunction by regulating glutamate transporters, glutamine synthetase expression and activity in diabetic retina. Neurochem Res. 2016; 41:1050-1064.
32. Yu LJ, Wu ML, Li H, Chen XY, Wang Q, Sun Y, Kong QY, Liu J. Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells. Neoplasia. 2008; 10:736-744.
33. Kassen SC, Thummel R, Campochiaro LA, Harding MJ, Bennett NA, Hyde DR. CNTF induces photoreceptor neuroprotection and Muller glial cell proliferation through two different signaling pathways in the adult zebrafish retina. Exp Eye Res. 2009; 88:1051-1064.
34. Samardzija M, Wenzel A, Aufenberg S, Thiersch M, Reme C, Grimm C. Differential role of Jak-STAT signaling in retinal degenerations. FASEB J. 2006; 20:2411-2413.
35. Wenzel A, Grimm C, Samardzija M, Reme CE. Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retin Eye Res. 2005; 24:275-306.
36. Zhang F, Lu YF, Wu Q, Liu J, Shi JS. Resveratrol promotes neurotrophic factor release from astroglia. Exp Biol Med (Maywood). 2012; 237:943-948.
37. Cheng J, Rui Y, Qin L, Xu J, Han S, Yuan L, Yin X, Wan Z. Vitamin D combined with resveratrol prevents cognitive decline in SAMP8 mice. Curr Alzheimer Res. 2017.
38. Suh M, Sauve Y, Merrells KJ, Kang JX, Ma DW. Supranormal electroretinogram in fat-1 mice with retinas enriched in docosahexaenoic acid and n-3 very long chain fatty acids (C24-C36). Invest Ophthalmol Vis Sci. 2009; 50:4394-4401.
39. Miyauchi O, Mizota A, Adachi-Usami E, Nishikawa M. Protective effect of docosahexaenoic acid against retinal ischemic injury: an electroretinographic study. Ophthalmic Res. 2001; 33:191-195.
40. Murayama K, Yoneya S, Miyauchi O, Adachi-Usami E, Nishikawa M. Fish oil (polyunsaturated fatty acid) prevents ischemic-induced injury in the mammalian retina. Exp Eye Res. 2002; 74:671-676.
41. Benolken RM, Anderson RE, Wheeler TG. Membrane fatty acids associated with the electrical response in visual excitation. Science. 1973; 182:1253-1254.
42. Wheeler TG, Benolken RM, Anderson RE. Visual membranes: specificity of fatty acid precursors for the electrical response to illumination. Science. 1975; 188:1312-1314.
43. Tanito M, Brush RS, Elliott MH, Wicker LD, Henry KR, Anderson RE. High levels of retinal membrane docosahexaenoic acid increase susceptibility to stress-induced degeneration. J Lipid Res. 2009; 50:807-819.
44. Ramchani-Ben Othman K, Cercy C, Amri M, Doly M, Ranchon-Cole I. Dietary supplement enriched in antioxidants and omega-3 protects from progressive light-induced retinal degeneration. PLoS One. 2015; 10:e0128395.
45. Li F, Marchette LD, Brush RS, Elliott MH, Le YZ, Henry KA, Anderson AG, Zhao C, Sun X, Zhang K, Anderson RE. DHA does not protect ELOVL4 transgenic mice from retinal degeneration. Mol Vis. 2009; 15:1185-1193.
46. Agbaga MP, Mandal MN, Anderson RE. Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein. J Lipid Res. 2010; 51:1624-1642.
47. Liu A, Chang J, Lin Y, Shen Z, Bernstein PS. Long-chain and very long-chain polyunsaturated fatty acids in ocular aging and age-related macular degeneration. J Lipid Res. 2010; 51:3217-3229.
48. Phillips MJ, Webb-Wood S, Faulkner AE, Jabbar SB, Biousse V, Newman NJ, Do VT, Boatright JH, Wallace DC, Pardue MT. Retinal function and structure in Ant1-deficient mice. Invest Ophthalmol Vis Sci. 2010; 51:6744-6752.
49. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959; 37:911-917.
50. Martin RE, Elliott MH, Brush RS, Anderson RE. Detailed characterization of the lipid composition of detergent-resistant membranes from photoreceptor rod outer segment membranes. Invest Ophthalmol Vis Sci. 2005; 46:1147-1154.
51. Agbaga MP, Brush RS, Mandal MN, Henry K, Elliott MH, Anderson RE. Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids. Proc Natl Acad Sci U S A. 2008; 105:12843-12848.
